Docket Room
HR 8339·Federal·house

Drug Origin Transparency Act of 2026

In CommitteeFiled Apr 16, 2026
Sponsor: Rep. Matsui, Doris O. [D-CA-7] (D)
Latest Action

Referred to the House Committee on Energy and Commerce.

Apr 16, 2026

Summary

The bill changes the Federal Food, Drug, and Cosmetic Act so that companies must disclose who supplies each ingredient and how much is used, and must put that information on the product label. It applies to manufacturers, ingredient suppliers, packers and distributors of prescription and over‑the‑counter drugs. The goal is to give regulators and consumers clearer insight into where drugs come from.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Share

Track this bill

Get real-time alerts when HR 8339 changes status, plus AI-powered summaries and stage predictions.

Sign up free
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice